Trial intelligence / Profile preview

Lidocaine vs Dexmedetomidine for Intraoperative Bleeding in FESS

NCT06848764Completed

Sponsor
Ain Shams University
Start
Jul 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in intraoperative bleeding comparing Lidocaine group with Dexmedetomidine group (2 arms). Primary endpoint: Surgical field. Started Jul 2024; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidine
03

Conditions

intraoperative bleeding

Beyond the preview

Go deeper on NCT06848764.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06848764.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call